Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
Clinical trial NCT07731789 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07731789
- Sponsor
- University of Washington
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-31
- Primary completion
- 2030-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.